Inactivation of SARS-CoV-2 Laboratory Specimens

28Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Cite

CITATION STYLE

APA

Haddock, E., Feldmann, F., Shupert, W. L., & Feldmann, H. (2021). Inactivation of SARS-CoV-2 Laboratory Specimens. American Journal of Tropical Medicine and Hygiene, 104(6), 2195–2198. https://doi.org/10.4269/ajtmh.21-0229

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free